Tag: adverum biotechnologies

June 10, 2019

Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022

Adverum Biotechnologies (NASDAQ:ADVM) has announced it has dosed the first patient in its second cohort of the ongoing OPTIC phase...
May 16, 2019

Adverum Biotechnologies Provides Update on OPTIC Phase 1 Trial for ADVM-022

Adverum Biotechnologies (NASDAQ:ADVM) has announced that the US Food and Drug Administration (FDA) has removed the clinical hold on the...
February 11, 2019

Adverum Biotechnologies Announces Presentation of Preclinical Long-Term Safety Data of ADVM-022

Adverum Biotechnologies (NASDAQ:ADVM) has announced non-human private (NHP) long-term safety data of ADVM-022,  gene therapy currently in phase 1 to...
December 4, 2018

5 Top NASDAQ Genetics Stocks Year-to-Date

As Q4 and 2018 come to a close, the Investing News Network profiles the five top genetics stocks on the...
December 3, 2018

Adverum Biotechnologies Announces Publication of Preclinical Long-Term Expression and Efficacy Data in Molecular Therapy

Adverum Biotechnologies (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today announced the...
November 19, 2018

Adverum Announces First Patient Dosed in OPTIC Phase 1 Trial of ADVM-022

Adverum Biotechnologies (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today announced that...
October 4, 2018

5 Top NASDAQ Genetics Stocks of Q3 2018

With Q3 2018 over, we've profiled the five top NASDAQ genetics stocks year-to-date. Here's a look at what they've been...